Portfolio company
CrescentDX
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops and markets diagnostic screening tests for osteoporosis and hip fracture risk assessment for medical physicians and healthcare providers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
ORISDX
This company develops non-invasive salivary diagnostic tests for early oral cancer detection, serving dentists, oncologists and primary care providers.
BMTfemme
This company develops rapid antigen diagnostic tests and breast screening technology for healthcare providers and individual consumers.
Nimble Dx
This company develops a non-invasive medical device for clinicians to monitor and diagnose complications in patients with implanted cardiovascular stents.
POROUS
This company develops non-invasive ultrasound systems for early osteoporosis detection and cortical bone microstructure analysis for healthcare professionals and clinical researchers.
Voc Diagnostics
This company develops diagnostic instruments using machine learning and sensor technology to detect ovarian cancer from blood plasma samples for healthcare providers.
Cytox
This company develops non-invasive genetic tests for Alzheimer's disease risk assessment and patient stratification for clinicians and pharmaceutical researchers.
Ischemia Technologies
This company develops and manufactures in vitro diagnostic products for cardiovascular and acute care medicine to assist clinicians in detecting cardiac ischemia.
StrokeDx
This company develops portable, non-invasive neuroimaging devices and software for rapid bedside stroke detection and monitoring for healthcare providers and emergency services.
